Welgene Biotech Co., Ltd. (6661)
Market Closed
15 Jun, 05:30
TWSE 
HKEX Primary TWSE NT$
16. 00
0
0%
NT$
- Market Cap
- P/E Ratio
1.2% Div Yield
5,000 Volume
- Eps
NT$ 16
Previous Close Want to track 6661 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Welgene Biotech Co., Ltd. (6661) Statistics
Valuation metrics
Market Cap -
Enterprise value 389.36M
Trailing P/E (ttm) -963.47
Forward P/E -
PEG ratio 8.07
Price/Sales (ttm) 0.98
Price/Book (mrq) 1.36
Enterprise Value/Revenue 1.02
Enterprise Value/EBITDA 12.52
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 13.62K
Average volume (90 days) 8.27K
Price summary
52-Week low 15.5
52-Week high 24.05
Beta -
50-Day moving average 17.3
200-Day moving average 18.36
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1,080:1,000
Last split Date 17 Aug 2018
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0%
Operating margin -0%
Operational effectiveness
Return on assets -0%
Return on equity -0%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 16.38
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.02
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 8.75
Total debt (mrq) -
Total Debt/Equity (mrq) 0.79
Current ratio (mrq) 1.96%
Book value per share (mrq) 12.01
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
